金城医药 (300233.sz)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(金城医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
单季度财务指标:
 单季度销售毛利率(%) 45.0047.0041.0044.0043.0044.0053.0046.0043.00
 单季度销售净利率(%) 10.005.004.006.007.002.006.0012.0012.00
 单季度净资产收益率ROE(%) 2.001.001.001.001.00-1.003.003.00
 单季度总资产净利率ROA(%) 2.001.001.001.001.00-1.002.002.00
单季度财务摘要:
 单季度营业总收入(元) 931,696,553.00969,559,792.00863,459,371.00875,766,755.00829,526,542.00914,461,793.00739,470,119.00898,722,852.00953,062,199.00
 单季度营业总成本(元) 824,597,996.00906,918,277.00816,266,241.00805,283,369.00765,199,921.00850,037,333.00702,691,780.00769,945,459.00810,774,618.00
 单季度营业收入(元) 931,696,553.00969,559,792.00863,459,371.00875,766,755.00829,526,542.00914,461,793.00739,470,119.00898,722,852.00953,062,199.00
 单季度营业利润(元) 115,649,572.0050,332,878.0041,342,155.0065,426,632.0068,747,552.0014,832,886.0054,942,237.00138,836,901.00145,165,252.00
 单季度利润总额(元) 115,554,756.0049,106,163.0040,609,025.0065,455,630.0070,236,722.0017,618,188.0055,481,668.00128,629,167.00144,236,963.00
 单季度净利润(元) 89,158,928.0046,655,976.0035,882,462.0055,892,892.0054,879,669.0018,785,005.0042,882,141.00108,140,512.00116,066,574.00
 单季度归属母公司股东的净利润(元) 82,971,350.0042,229,002.0030,770,939.0051,554,762.0050,154,655.0014,970,165.0039,423,510.00106,492,018.00112,478,901.00
 单季度经营活动产生的现金流量(元) 41,373,197.00203,154,102.00179,537,319.00254,680,375.0026,703,337.0047,398,858.00223,880,246.0030,144,869.00-45,797,444.00
 单季度投资活动产生的现金流量(元) -51,415,125.00-152,622,145.00-28,039,668.00-56,057,952.00-73,268,997.00-9,739,677.00-78,736,615.00-180,324,780.00-89,022,464.00
 单季度筹资活动产生的现金流量(元) 25,751,267.00-149,971,860.00-570,141.00-175,753,258.0082,984,423.00-95,311,043.00-44,090,916.0086,226,793.0057,004,585.00
 单季度现金及现金等价物净增加(元) 16,980,050.00-98,476,639.00152,088,472.0024,993,902.0035,635,968.00-53,516,830.00101,664,319.00-64,244,158.00-77,971,250.00

前瞻产业研究院